1
|
Perelló-Capo J, Quílez-Conde JC, Gutiérrez-Alés J, Lobo-Abascal P, Parra-Ribes I, Cristóbal-García I, Andeyro-García M, Herrero-Conde M, Rius-Tarruella J, Calaf-Alsina J. Use of Contraceptive Methods Among Women in the General Population and Female Gynecologists in Spain: the ELEGIAN Survey. Womens Health Rep (New Rochelle) 2023; 4:478-486. [PMID: 37818182 PMCID: PMC10561741 DOI: 10.1089/whr.2023.0048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Accepted: 07/27/2023] [Indexed: 10/12/2023]
Abstract
Background The contraceptive preferences of obstetricians and gynecologists (OB/GYNs) are thought to influence the contraceptive counseling they provide. The purpose of this study was to assess contraceptive preferences of OB/GYNs and women in the general population (WGP) in the current Spanish contraceptive scenario. Materials and Methods Anonymous online survey of 100 OB/GYNs and 1,217 WGP aged 23-49 years. Results WGP were younger (35.3 ± 7.3 vs. 37.9 ± 6.2 years, respectively) and less likely to have stable partners (64.7% vs. 84.0%) and children (49.1% vs. 62.0%) (all p < 0.05 vs. OB/GYNs). Seventy-nine percent versus 82%, respectively, used contraceptive methods, with condoms used most frequently by WGP (37% vs. 22% by OB/GYNs; p < 0.05) and pills by OB/GYNs (26% vs. 21% by WGP; p > 0.05). Intrauterine devices (IUDs) were more frequently used by OB/GYNs (20% vs. 5%; p < 0.05), especially the levonorgestrel-releasing intrauterine devices (LNG-IUDs) (18% vs. 2.6%; p < 0.05). The highest-rated methods were condoms among WGP and LNG-IUDs among OB/GYNs. Effectiveness was the most valued attribute of contraceptive methods for both. Reasons related to convenience were the main reason for choosing IUDs. OB/GYNs prescribed the contraceptive method in 40% of cases. Conclusions Our study reveals differences between female OB/GYNs and WGP in contraceptive methods use and rating. The use of LNG-IUDs was much higher among OB/GYNs.
Collapse
Affiliation(s)
- Josep Perelló-Capo
- Department of Obstetrics and Gynecology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Departament of Pediatrics, Obstetrics and Gynecology, Preventive Medicine and Public Health, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - José C. Quílez-Conde
- Department of Obstetrics and Gynecology, Hospital Universitario Basurto, Bilbao, Spain
| | - José Gutiérrez-Alés
- Contraception and Sexual and Reproductive Health, Universidad de Alcalá (UAH), Madrid, Spain
| | - Paloma Lobo-Abascal
- Department of Obstetrics and Gynecology, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain
- Biomedical and Health Sciences, Obstetrics and Gynecology, Universidad Europea, Madrid, Spain
| | - Inmaculada Parra-Ribes
- Sueca Sexual and Reproductive Health Unit, La Ribera Department of Obstetrics and Gynecology, Conselleria de Sanitat Universal i Salut Pública, Valencia, Spain
| | - Ignacio Cristóbal-García
- Department of Obstetrics and Gynecology, Hospital Clínico San Carlos, Universidad Francisco de Vitoria, Madrid, Spain
| | - Mercedes Andeyro-García
- Department of Obstetrics and Gynecology, Hospital General de Villalba, Madrid, Spain
- Obstetrics and Gynecology Department, Faculty of Medicine, Universidad Alfonso X, Madrid, España
| | | | | | - Joaquim Calaf-Alsina
- Department of Obstetrics and Gynecology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- Departament of Pediatrics, Obstetrics and Gynecology, Preventive Medicine and Public Health, Universitat Autònoma de Barcelona, Barcelona, Spain
| |
Collapse
|
2
|
Perelló-Capo J, Rius-Tarruella J, Andeyro-García M, Calaf-Alsina J. Sensitivity to Change of the SAMANTA Questionnaire, a Heavy Menstrual Bleeding Diagnostic Tool, After 1 Year of Hormonal Treatment. J Womens Health (Larchmt) 2023; 32:208-215. [PMID: 36576860 DOI: 10.1089/jwh.2022.0155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Background: The validated SAMANTA questionnaire allows identification of women with heavy menstrual bleeding (HMB); that is, with excessive menstrual bleeding that interferes with quality of life (QoL). We assessed its value for monitoring HMB treatment in clinical practice. Material and Methods: This is a prospective observational study conducted between December 2018 and March 2021 in consecutively recruited women with HMB attending gynecologists' offices who started a hormonal treatment. Sociodemographic characteristics were recorded at enrollment. At baseline and month 12, we assessed the HMB (SAMANTA questionnaire), the global impression of menstrual bleeding severity in patients (PGI-S) and clinicians (CGI-S), and the QoL (SF36). At month 12, we assessed the global impression of menstrual bleeding change in patients (PGI-C) and clinicians (CGI-C). Changes in SAMANTA questionnaire score at month 12 were compared with the presence of amenorrhea and changes in blood loss, menstrual period duration, and PGI-S, PGI-C, CGI-S, and CGI-C. Results: The study included 371 women aged 41.2 ± 6.5 years, 87% of whom were using the levonorgestrel intrauterine system. The SAMANTA questionnaire score significantly decreased in 97.3% of women. The decrease was greater in women reporting a reduction in blood loss, shorter menstrual bleeding duration, or a strong improvement in menstrual bleeding severity (PGI-S and CGI-S) or amount (PGI-C and CGI-C) (p < 0.001 for all), but not amenorrhea. SF-36 domains improved significantly; changes being inversely associated with changes in the SAMANTA questionnaire score. Conclusions: The SAMANTA questionnaire seems a valuable tool for monitoring hormonal treatment for HMB. ClinicalTrials.gov identifier NCT03751800.
Collapse
Affiliation(s)
- Josep Perelló-Capo
- Department of Obstetrics and Gynecology, Hospital de Sant Pau, Barcelona, Spain.,Paediatrics, Obstetrics and Gynecology, and Preventive Medicine and Public Health Department, Universitat Autònoma de Barcelona, Barcelona, Spain
| | | | | | - Joaquim Calaf-Alsina
- Department of Obstetrics and Gynecology, Hospital de Sant Pau, Barcelona, Spain.,Paediatrics, Obstetrics and Gynecology, and Preventive Medicine and Public Health Department, Universitat Autònoma de Barcelona, Barcelona, Spain
| |
Collapse
|